Count | |
| 3 | |
| 19 | |
| 6 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 8 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 5 | |
| 14 | |
| 2 | |
| 1 | |
alpha-Glucosidases/administration & dosage/adverse effects/*antagonists & | 1 |
| 13 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 5 | |
| 1 | |
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 16 |
| 1 | |
| 2 | |
| 21 | |
| 2 | |
| 1 | |
| 4 | |
| 5 | |
| 7 | |
| 1 | |
| 13 | |
| 50 | |
| 14 | |
| 1 | |
| 1 | |
| 8 | |
| 3 | |
| 26 | |
| 32 | |
| 6 | |
| 7 | |
| 2 | |
| 6 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 16 | |
| 53 | |
| 21 | |
| 1 | |
| 3 | |
| 16 | |
| 1 | |
| 1 | |
| 1 | |
| 8 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 2 | |
| 1 | |
| 28 | |
| 1 | |
| 7 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 4 | |
| 1 | |
| 6 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |